Long-term use of osteoporosis drugs may have risk
March 10, 2010 (WLS) -- The government is reviewing certain bone-building drugs to see if they increase the risk of femur fractures.
The Food and Drug Administration will look into four drugs used to treat osteoporosis: Fosomax, Actonel, Boniva and Reclast. The drugs are commonly prescribed to treat osteoporosis and build bone mass.
The FDA is also asking doctors to report any side effects seen with the medications.
Some doctors say patients currently taking the medications should not stop taking them because the benefits outweigh the risk.
"The risk benefit is still in a woman's favor to stay on a bisphosphonate to avoid fractures of the spine or the typical hip fracture. Because the morbidity mortality rate of hip fractures is especially in older women is just huge," said Dr. Sheila Dugan, Rush University.
Dr. Dugan says people with thigh or hip bone pains should consider getting an MRI because those symptoms may indicate that the bone is weakening before it breaks.
- Boy, 13, describes Aurora home invasion
- Ga lottery winner claims Mega Millions prize
- Video: I-Team Mall Security
- ABC7 Weather Forecast
- Cardinal George celebrates 50 years in priesthood
- Janet Rowley, U of C cancer research pioneer, dies at 88
- Maine West coach trial gets testimony from ex-soccer player
- Mega Millions drawing leads to $1M ticket in Chicago
- Mom honors son's memory by delivering toys to sick children
- Naperville fire kills 2, injures 3
- ADM to move headquarters to Chicago without tax breaks
- Durbin presses regulators to prevent tanker tragedies
- Illini grad to go for spacewalk on International Space Station
- abcnews: 'Duck Dynasty' Puts Star on Hiatus